Showing posts with label Pharma Marketing Talk. Show all posts
Showing posts with label Pharma Marketing Talk. Show all posts

Pre-Screening, Post-Screening, or No Screening at All - What's the Best Moderation Practice for Pharma Social Media?

As more and more pharmaceutical companies launch social networking platforms associated with their brands, some will allow users (consumers, patients, physicians, and the anonymous rabble) to post comments as part of ongoing discussions about drugs and/or the conditions they treat. Recent pharma experience with social media discussions (see "What Sanofi-Aventis Learned from Its FaceBook Experience & What the Experts Recommend It Do Now") demonstrate how important it is to properly manage online communities. Perhaps the most important management tool is moderation.

Basically, there are three options for moderation:
  1. Pre-screening comments BEFORE they are posted
  2. Post-screening comments AFTER they are posted
  3. NO screening/moderation at all
I am already on record as being against no moderation (see "Pharma Should Leave Unmoderated SM Discussions to 3rd Parties"). But I am on the fence regarding pre- vs. post-screening.

A few organizations that submitted comments to the FDA in response to its questions about regulating pharma's use of social media addressed the issue of moderation (see, for example, "Accountability for Pharma Content on Social Media Sites"). LiveWorld, Inc. -- a social marketing agency with 20+ years creating, operating, and moderating online communities -- submitted the most detailed comments regarding moderation (find LiveWorld's comments here).

In tomorrow's Pharma Marketing Talk LIVE podcast ("Online Community Management Moderation Best Practices & Other Tips for Pharma Social Media Managers"), I will be interviewing Jenna Woodul, who is the co-founder and Chief Community Officer of LiveWorld. Jenna and LiveWorld believe that the FDA should not issue specific regulations about moderation of comments on pharma-owned and operated social networks. The questions I have for Jenna are:
  • What's wrong with how many pharma companies are currently managing their social media campaigns?
  • What's your opinion of moderation? Should pharmacos moderate posts BEFORE they are published on their social media sites? Or should they only remove posts that violate the terms AFTER they are posted automatically?
  • Can you explain what kind of moderation is possible for social networking sites such as Facebook and Youtube? Are there limitations that pharma companies should be aware of? How can these limitations be overcome?
You can listen to this podcast live via the Web at 2 PM Eastern time, April 15, 2010 (or listen to the archive afterward). You can also call in during the show to ask questions or participate in discussion: (347) 996-5894. See here for more details.

SURVEY
To help me prepare for the show, please respond to the "Moderation of Social Network Sites Operated by Pharma Companies" online survey that I prepared. It will only take a few minutes of your time. Let me know whether you think pharma moderation best practice is pre-moderation, post-moderation or no moderation at all. What are the benefits/drawbacks of each? Take the survey here.

What Has Sanofi-Aventis Learned from Its Facebook Experience?

NOTE: This interview has been rescheduled for Tuesday, April 6, 2010 at 2:00 PM EDT.

Dennis Urbaniak, VP U.S. Diabetes and former VP of Innovation and New Customer Channels, Sanofi-Aventis, called what's happening on the Wall of his company's VOICES Facebook page a "key learning experience." He made this comment in a call to me last week. To explain what he meant by that, I invited Mr. Urbaniak to be a guest on my Pharma Marketing Talk show this week (click here for details).



What Sanofi-Aventis Learned from Its FaceBook Experience & What the Experts Recommend It Do Now

Dennis UrbaniakA conversation with Dennis Urbaniak, VP U.S. Diabetes at sanofi-aventis, about the recent activity on S-A's VOICES corporate Facebook page. We'll discuss the lessons learned and hear advice from independent experts. Urbaniak is willing to answer questions and consider advice from listeners.

A FREE Pharma Marketing Talk LIVE Podcast and Online Chat!
Tuesday, April 6, 2010 * 2:00 PM Eastern US

This will be the FIRST time that Dennis Urbaniak/S-A will speak on this issue to the "press" (me) and in an open forum.


I warned Urbaniak that this is a LIVE interview and that people can call in with questions or post questions in a live chat window. He responded by saying that he welcomed the discussion and would listen to any recommendations from experts and critics alike. This is the best way to really learn something from the experience and help the industry do a better job in the future.

So, I welcome all the "experts" out there who think they can contribute to the "learning experience" to not only listen in, but to call in and join the discussion. The number to call is (347) 996-5894. Talk to you then!